Aujeszky's disease
pseudorabies

One of the conditions for placing pigs on the market is that they should originate from a region or country free from Aujeszky's disease.

There are, however, two diseases on the list today, for which Member States currently receive funding: Aujeszky's disease and bovine leucosis.

They found that some existing vaccines against pseudorabies (also termed Aujeszky's disease) had deletions in their viral genome (amongst which the gE gene.

Research on pseudorabies virus (PrV), the causative agent of Aujeszky's disease in pigs, has pioneered animal disease control with genetically modified vaccines.

Pseudorabies virus is the causative agent of Aujeszky's disease in pigs and bovine herpesvirus 1 is the causative agent of bovine infectious rhinotracheitis and pustular vulvovaginitis.

Pseudorabies, PRV, Aujeszky's disease, infectious bulbar paralysis or 'mad itch', is caused by a virus with icosahedral symmetry and belongs to the subfamily Alphaherpesvirinae within the family Herpesviridae.

It is caused by Suid herpesvirus 1 (SuHV-1), which is also called pseudorabies virus (PRV) and is also known as Aujeszky's disease, and in cattle as mad itch.

Aujeszky's disease in pigs, which the Commission proposed to exclude, is also the subject of a planned programme for Portugal, where failure to eradicate the disease means that it is impossible to export pigs to some markets.

The European Commission's proposed adjustment of the list of diseases involving the removal of bovine leucosis and Aujeszky's disease, may lead to significant cuts in the preventive programmes in place, or even to them being completely halted.

Designated notifiable diseases under the Diseases of Animals Act include anthrax, foot-and-mouth disease, fowl pest, bovine tuberculosis, BSE, scrapie, swine vesicular disease, Aujeszky's disease, bovine leukemia virus, rabies and warble fly.

The varicellovirus genus contains several closely related viruses, including Varicella zoster virus (human herpesvirus 3), the causative agent of chickenpox in humans, and Pseudorabies virus (Suid herpesvirus 1), the causative agent of Aujeszky's disease.

Diseases and parasites that can afflict modern domestic pigs include foot-and-mouth disease, swine vesicular disease, swine fever, swine erysipelas, anthrax, enteritis, virus pneumonia, blue ear, stress-related oedema, Aujeszky's disease, Teschen disease, anaemia, arthritis, rheumatism, metritis, mastitis, roundworms, lungworms, mange and lice.

The name "pseudorabies" came from the symptoms similar to rabies that it caused in rabbits.

It also destroys viruses including canine parvovirus, parainfluenza-3 and pseudorabies.

The earliest reports of a disease suspected to be pseudorabies were in 1813 in the United States.

For a use in mapping neurons see the applications of pseudorabies in neuroscience.

Although no specific treatment for acute infection with pseudorabies virus is available, vaccination can alleviate clinical signs in pigs of certain ages.

Due to the presence of vesicular stomatitis and pseudorabies on the island, no more live pigs may be removed from the island.

By using pseudorabies viruses with different fluorescent reporters, dual infection models can parse complex synaptic architecture.

The DIVA strategy has been applied in various countries and successfully eradicated pseudorabies virus.

In 2004 the commercial swine population of the United States was declared free of pseudorabies, but the disease remained in feral pig populations.

Pseudorabies has been reported in other mammals, including brown bears, and black bears, Florida panthers, raccoons, coyotes, and whitetail deer.

Two laboratories provide serological and microbiological diagnostic services for cattle brucellosis, swine brucellosis, and pseudorabies.

They found that some existing vaccines against pseudorabies (also termed Aujeszky's disease) had deletions in their viral genome (amongst which the gE gene.

Pseudorabies double labeling procedure The unique design of these experiments is the use of two immunohistochemically distinguishable pseudorabies viruses.

Research on pseudorabies virus (PrV), the causative agent of Aujeszky's disease in pigs, has pioneered animal disease control with genetically modified vaccines.

Goats can become infected with various viral and bacterial diseases, such as foot-and-mouth disease, caprine arthritis encephalitis, caseous lymphadenitis, pinkeye, mastitis, and pseudorabies.

The Upjohn Company received two patents this week involving a new test, developed through genetic engineering, to detect in farm animals a deadly and contagious herpes virus known as "pseudorabies."

In those studies the virus used was the Bartha strain of pseudorabies virus that is more virulent than the viruses used in the current work [ 16 ] .

The word "pseudorabies" means "false rabies," or "rabies-like;" pseudorabies is related to the herpes virus, not the rabies virus.

There are commercial preparations available, but chopped bovine pancreas from the butcher can also be used (pork pancreas should not be used because of the rare transmission of pseudorabies).

Aladár Aujeszky (11 January 1869 Pest - 9 March 1933 Budapest) was a Hungarian veterinary pathologist, professor of bacteriology and microbiologist, noted for his work on Pseudorabies.

The two pseudorabies viruses used in these experiments were PRV-Bartha Blu and PRV-152 and were donated by Dr. L.W. Enquist.

It is caused by Suid herpesvirus 1 (SuHV-1), which is also called pseudorabies virus (PRV) and is also known as Aujeszky's disease, and in cattle as mad itch.

In addition, the same group demonstrated that the DNA binding domain fusion polypeptide of the homologous IE180 protein of pseudorabies virus (PRV) interacted with its promoter in a similar manner (27).

To do this we have employed the unique technique of two immunohistochemically distinguishable pseudorabies viruses, which will simultaneously be injected, one to each organ, as neuroanatomical tracers to determine each of the central nervous system distributions [ 9 10 ] .

The HIV-1 viral envelope glycoprotein gp120 can directly inhibit the phosphorylation of GFAP and GFAP levels can be decreased in response to chronic infection with HIV-1, varicella zoster, and pseudorabies.